Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based Study
CONCLUSIONS: Despite increases in autoHCT utilization, sociodemographic disparities remain. Identifying and mitigating barriers to autoHCT is essential to ensuring more equitable access to this highly effective therapy.PMID:38195324 | DOI:10.1016/j.clml.2023.12.009
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Naseem S Esteghamat Ann Brunson Aaron S Rosenberg Sara J Schonfeld Bryan Valcarcel Renata Abrah ão Julianne J P Cooley Christa L Meyer Jeffery J Auletta Lindsay M Morton Lori Muffly Ted Wun Theresa H M Keegan Source Type: research
More News: Cancer | Cancer & Oncology | Health Insurance | Insurance | Lymphoma | Medicaid | Medicare | Myeloma | Study | Transplants | Uninsured